Maio M, Brasoveanu LI, Coral S, Sigalotti L, Lamaj E, Gasparollo A, Visintin A, Altomonte M, Fonsatti E (agosto de 1998). "Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review)". International Journal of Oncology13 (2): 305–318. PMID9664126. doi:10.3892/ijo.13.2.305.
Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z (xullo de 2004). "Cell signals transduced by complement". Molecular Immunology41 (6–7): 583–597. PMID15219997. doi:10.1016/j.molimm.2004.04.007.
Li B, Chu X, Gao M, Xu Y (2011). "The effects of CD59 gene as a target gene on breast cancer cells". Cellular Immunology272 (1): 61–70. PMID22000275. doi:10.1016/j.cellimm.2011.09.006.
Maio M, Brasoveanu LI, Coral S, Sigalotti L, Lamaj E, Gasparollo A, Visintin A, Altomonte M, Fonsatti E (agosto de 1998). "Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review)". International Journal of Oncology13 (2): 305–318. PMID9664126. doi:10.3892/ijo.13.2.305.
Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z (xullo de 2004). "Cell signals transduced by complement". Molecular Immunology41 (6–7): 583–597. PMID15219997. doi:10.1016/j.molimm.2004.04.007.
Li B, Chu X, Gao M, Xu Y (2011). "The effects of CD59 gene as a target gene on breast cancer cells". Cellular Immunology272 (1): 61–70. PMID22000275. doi:10.1016/j.cellimm.2011.09.006.